CIK 0000748592
- Non-accelerated filer
- Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 311103425
- Phone
- +1 617-798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Executive or director change
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Material agreement
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- 8-K Event Executive or director change
- DEF 14A Proxy Proxy Statement
Page 14 of 22 · 427 filings